New metformin derivative HL156A prevents oral cancer progression by inhibiting the insulin-like growth factor/AKT/mammalian target of rapamycin pathways.

about

Antioxidant modifications induced by the new metformin derivative HL156A regulate metabolic reprogramming in SAMP1/kl (-/-) mice Cytotoxic effect of Drimia maritima bulb extract and induction of mitochondrial apoptotic signaling in human breast cancer cells, MCF-7 and MDA-MB-468

P2860

Q58735442-05F4FEC6-6C0E-42E6-B20B-A6BA26311546 Q59135222-2C733A6E-20AF-4000-860C-3FCE0E25C321

P2860

New metformin derivative HL156A prevents oral cancer progression by inhibiting the insulin-like growth factor/AKT/mammalian target of rapamycin pathways.

Item

http://www.wikidata.org/entity/Q47246957

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

New metformin derivative HL156 ...... target of rapamycin pathways.

@en

New metformin derivative HL156 ...... target of rapamycin pathways.

@nl

type

Item

label

New metformin derivative HL156 ...... target of rapamycin pathways.

@en

New metformin derivative HL156 ...... target of rapamycin pathways.

@nl

prefLabel

New metformin derivative HL156 ...... target of rapamycin pathways.

@en

New metformin derivative HL156 ...... target of rapamycin pathways.

@nl

P1476

New metformin derivative HL156 ...... target of rapamycin pathways.

@en

P2093

Soo-A Kim

http://www.w3.org/2001/XMLSchema#string

Yun Soo Jeong

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacologic Therapy of Diabetes and Overall Cancer Risk and Mortality: A Meta-Analysis of 265 Studies

Matrix metalloproteinases in tumor invasion

Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

Inhibiting stemness and invasive properties of glioblastoma tumorsphere by combined treatment with temozolomide and a newly designed biguanide (HL156A).

mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma.

Antiproliferative action of metformin in human lung cancer cell lines.

Dichloroacetate enhances apoptotic cell death via oxidative damage and attenuates lactate production in metformin-treated breast cancer cells.

Metformin may function as anti-cancer agent via targeting cancer stem cells: the potential biological significance of tumor-associated miRNAs in breast and pancreatic cancers

Matrix metalloproteinases in tumor invasion: role for cell migration.

Elevated NF-κB activation is conserved in human myocytes cultured from obese type 2 diabetic patients and attenuated by AMP-activated protein kinase

P304

699-709

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CAS.13482

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P50

Sang-Gun Ahn

Thuy Giang Lam

P577

2018-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29285837

http://www.w3.org/2001/XMLSchema#string

P921

metformin

Insulin

P932

5834796

http://www.w3.org/2001/XMLSchema#string

New metformin derivative HL156A prevents oral cancer progression by inhibiting the insulin-like growth factor/AKT/mammalian target of rapamycin pathways.

about

P2860

P2860

New metformin derivative HL156A prevents oral cancer progression by inhibiting the insulin-like growth factor/AKT/mammalian target of rapamycin pathways.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932